Research Analysts Offer Predictions for Shire PLC’s Q3 2017 Earnings (SHPG)

Shire PLC (NASDAQ:SHPG) – Equities researchers at SunTrust Banks increased their Q3 2017 EPS estimates for Shire PLC in a report issued on Monday. SunTrust Banks analyst J. Boris now forecasts that the biopharmaceutical company will earn $3.69 per share for the quarter, up from their prior estimate of $3.60. SunTrust Banks also issued estimates for Shire PLC’s Q4 2017 earnings at $3.92 EPS and FY2017 earnings at $14.97 EPS.

SHPG has been the subject of several other reports. BidaskClub lowered shares of Shire PLC from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. Barclays PLC lowered shares of Shire PLC from an “overweight” rating to an “equal weight” rating in a report on Friday, August 11th. Evercore ISI assumed coverage on shares of Shire PLC in a report on Wednesday, August 16th. They issued an “outperform” rating and a $196.00 price target for the company. Cantor Fitzgerald set a $222.00 price target on shares of Shire PLC and gave the company a “buy” rating in a report on Saturday, July 1st. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $213.00 price target on shares of Shire PLC in a report on Monday, October 2nd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $219.25.

COPYRIGHT VIOLATION NOTICE: This news story was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/10/20/research-analysts-offer-predictions-for-shire-plcs-q3-2017-earnings-shpg.html.

Shire PLC (NASDAQ SHPG) opened at 147.82 on Thursday. The firm has a 50-day moving average of $154.09 and a 200 day moving average of $164.39. Shire PLC has a 1-year low of $139.36 and a 1-year high of $192.64. The firm has a market cap of $44.03 billion, a P/E ratio of 66.14 and a beta of 1.63.

Shire PLC (NASDAQ:SHPG) last released its quarterly earnings data on Friday, October 27th. The biopharmaceutical company reported $3.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.66 by ($0.29). Shire PLC had a net margin of 4.70% and a return on equity of 14.10%.

Several hedge funds have recently added to or reduced their stakes in the business. Inspirion Wealth Advisors LLC raised its position in shares of Shire PLC by 0.4% during the 2nd quarter. Inspirion Wealth Advisors LLC now owns 1,944 shares of the biopharmaceutical company’s stock worth $321,000 after buying an additional 8 shares in the last quarter. Synovus Financial Corp raised its position in shares of Shire PLC by 0.4% during the 2nd quarter. Synovus Financial Corp now owns 2,780 shares of the biopharmaceutical company’s stock worth $458,000 after buying an additional 11 shares in the last quarter. Baldwin Investment Management LLC raised its position in shares of Shire PLC by 1.4% during the 2nd quarter. Baldwin Investment Management LLC now owns 1,626 shares of the biopharmaceutical company’s stock worth $269,000 after buying an additional 23 shares in the last quarter. Hartford Financial Management Inc. raised its position in shares of Shire PLC by 5.4% during the 2nd quarter. Hartford Financial Management Inc. now owns 621 shares of the biopharmaceutical company’s stock worth $102,000 after buying an additional 32 shares in the last quarter. Finally, American International Group Inc. raised its position in shares of Shire PLC by 1.2% during the 1st quarter. American International Group Inc. now owns 4,607 shares of the biopharmaceutical company’s stock worth $803,000 after buying an additional 54 shares in the last quarter. Institutional investors own 19.24% of the company’s stock.

The business also recently declared a semiannual dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 8th will be given a dividend of $0.1527 per share. The ex-dividend date is Thursday, September 7th. This represents a dividend yield of 0.21%. Shire PLC’s dividend payout ratio (DPR) is 41.07%.

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Earnings History and Estimates for Shire PLC (NASDAQ:SHPG)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply